Location

Rochester, Minnesota

Contact

witzig.thomas@mayo.edu Clinical Profile

Summary

Dr. Witzig has research interests in Hodgkin and non-Hodgkin lymphoma, multiple myeloma, and chronic lymphocytic leukemia. His laboratory research centers around the study of new agents that interfere with signal transduction pathways in lymphoma and myeloma cells. This has led to clinical trials of new agents that focus on the PI3 kinase signal transduction pathway. These agents include temsirolimus and everolimus. He has also been involved in some of the first studies of lenalidomide for lymphoma. He has a long-standing interest in radioimmunotherapy and is conducting new research that combines immunomodulatory agents with Zevalin radioimmunotherapy.

Recent Publications

See my publications

Professional Details

Primary Appointment

  1. Hematology

Joint Appointment

  1. Laboratory Medicine and Pathology

Academic Rank

  1. Professor of Medicine

Education

  1. Fellow - Medical Onocology Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  2. Research Fellowship - Clinical Hematology Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  3. Resident - Clinical Hematology Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  4. Resident - Department of Internal Medicine University of Iowa Hospitals and Clinics
  5. MD - Medicine University of Illinois College of Medicine
  6. BS - Biology Illinois State University
.
BIO-00025829

Mayo Clinic Footer